BOTPPF
RPRX icon

Board of the Pension Protection Fund’s Royalty Pharma RPRX Stock Holding History

Board of the Pension Protection Fund’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
22,800
+16,000
+235% +$833K 1.21% 47
2026
Q1 		$326K Sell
6,800
-1,100
-14% -$48.2K 0.3% 76
2025
Q4 		$305K Buy
7,900
+1,700
+27% +$64.8K 0.29% 64
2025
Q3 		$219K Sell
6,200
-6,800
-52% -$246K 0.21% 115
2025
Q2 		$468K Sell
13,000
-18,200
-58% -$603K 0.51% 72
2025
Q1 		$971K Buy
+31,200
New +$989K 1.11% 21

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Board of the Pension Protection Fund's RPRX Position: Q2 2026 in Review

Board of the Pension Protection Fund increased its Royalty Pharma (RPRX) stake by 235% in Q2 2026, buying an estimated $833K and bringing the position to 22,800 shares worth $1.28M. The position accounts for 1.21% of the portfolio, ranked #47.

Board of the Pension Protection Fund first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Board of the Pension Protection Fund held 22,800 shares of Royalty Pharma worth $1.28M as of Q2 2026.
  • Board of the Pension Protection Fund bought 16,000 Royalty Pharma shares in Q2 2026, an estimated $833K.
  • Royalty Pharma made up 1.21% of Board of the Pension Protection Fund's portfolio in Q2 2026, its #47 holding.
  • Board of the Pension Protection Fund first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Board of the Pension Protection Fund's 13F filing for Q2 2026, filed 7 Aug 2026.